Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

FDA Approval

ALYACEN 1/35

CompanyRPK Pharmaceuticals, Inc. (DUNS: 147096275)

Effective Date

June 7, 2023

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Manufacturing Establishments (1)

RPK Pharmaceuticals, Inc.

Labeler

RPK Pharmaceuticals, Inc.

DUNS Number

147096275

Products (1)

ALYACEN 1/35

NDC Product Code

53002-1780

Application Number

ANDA091634

Marketing Category

ANDA (C73584)

Effective Date

September 8, 2017

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy